{
  "id": 2212426,
  "title": "Chemotherapy-free treatment shows promise for some patients with metastatic breast cancer",
  "url": "https://urgent.news/2026/08/20/chemotherapy-free-treatment-shows-promise-for-some-patients-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T20:00:08.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-chemotherapy-free-treatment-patients-metastatic.html"
  },
  "original_language": "en",
  "account": "Researchers at the Icahn School of Medicine at Mount Sinai have discovered a promising chemotherapy-free treatment option for patients with HR-positive, HER2-positive metastatic breast cancer. The four-drug combination - anastrozole, palbociclib, trastuzumab, and pertuzumab - exhibited encouraging results in a phase 1/2 ASPIRE clinical trial, potentially offering a more convenient and less burdensome alternative to traditional chemotherapy. Published in the Journal of the National Cancer Institute, these findings were observed in 29 patients who demonstrated a 97% clinical benefit during the first six months of treatment, with a median progression-free survival of nearly 25 months. While these results warrant further investigation in larger randomized trials, they suggest that some patients may benefit from this targeted therapy regimen as a first-line treatment.",
  "summary": "Researchers at the Icahn School of Medicine at Mount Sinai found that a chemotherapy-free combination of four targeted therapies showed encouraging results in patients with HR-positive, HER2-positive metastatic breast cancer, offering a potential first-line treatment option that may be more convenient for some patients and avoids chemotherapy.",
  "key_points": [
    "Phase 1/2 ASPIRE trial demonstrates 97% clinical benefit in 29 patients within six months.",
    "Median progression-free survival of nearly 25 months observed in trial participants."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}